Search Results for "Avaglio Clinical Study"
Original Source: Roche's phase III AVAglio study meets co─primary endpoint of significantly improving PFS in people with glioblastoma
Roche has reported that the phase III AVAglio study of Avastin plus radiation and temozolomide chemotherapy in people with newly diagnosed glioblastoma met its co─primary endpoint of a significant improvement in progression─free survival (PFS).
Matching Channels
SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyle...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...
Gynecology is the study of diseases affecting the reproductive organs of women and girls. Add the Gynecology News Channel to your RSS reader;
A virus is a small infectious agent that can replicate only inside the living cells of organisms. Virus particles (known as virions) consist of two or three parts: the genetic material made from eit...
Matching News
The Phase III AVAglio study met its co-primary endpoint
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the phase III AVAglio study of Avastin plus radiation and temozolomide chemotherapy in people with newly diagnosed glioblastoma met its co-primary end...
Genentech phase III AVAglio study meets co-primary endpoint
Roche Group member, Genentech's phase III AVAglio study has met its co-primary endpoint of improving progression-free survival (PFS) in people with Glioblastoma.
Roche has reported that the phase III AVAglio study of Avastin plus radiation and temozolomide chemotherapy in people with newly diagnosed glioblastoma met its co─primary endpoint of a significant i...
Results from the positive phase III AVAglio study
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced results from the positive phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduc...
The Phase III AVAglio study met its co-primary endpoint of significantly improving progression-free survival in people with glioblastoma. Roche announced today that the phase III AVAglio study of Avas...
Avastin sees success in brain cancer trial
A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain cancer live longer without the disease getting worse. In the Phase III AVA...
Results from positive phase III AVAglio study...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the positive Phase III AVAglio study. The study showed Avastin® (bevacizumab) in...
Matching PubMed Articles
Impact of microdosing clinical study - Why necessary and how useful?
The microdose (MD) clinical study enables to select a "better" compound for new drug candidate that shows desirable PK profiles in human. This new methodology is highly expected to streamline the drug...
This research study examined whether a transfer of learning (i.e., growth in clinical competency) occurred from the simulation laboratory to the clinical bedside and if it did occur, how. The study de...
To study the expression levels and clinical significance of Argonaute2 (EIF2C2) on colonic carcinomas and normal tissues.
Successful and Unsuccessful Clinical Nursing Students.
This study describes the characteristics of successful and unsuccessful clinical performance in prelicensure nursing students. Clinical evaluation is an important role of nurse educators; however, man...